Immunocore Holdings (IMCR) reported Q1 net income Wednesday of $0.10 per diluted share, swinging from a loss of $0.49 a year earlier.

Analysts polled by FactSet expected a loss of $0.38.

Revenue for the quarter ended March 31 was $93.9 million, up from $70.5 million a year earlier.

Analysts surveyed by FactSet expected $86.5 million.

The company said that as of March 31, it has $837 million in cash, cash equivalents and marketable securities.

Shares of the company were up 2.6% in recent Wednesday premarket activity.